SCHEMBL1592093

SCHEMBL1592093

C=CC(=O)NCCCCCCCNC(=O)C=C

nearest known ligand 0.79

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ZDHHC20 Q5W0Z9 1/20 0.79
▸ ZDHHC2 Q9UIJ5 1/20 0.79
▸ ALDH1A1 P00352 3/20 0.59
▸ MAPK1 P28482 2/20 0.59
▸ TSHR P16473 1/20 0.59
▸ TDP1 Q9NUW8 1/20 0.59
▸ TGM2 P21980 4/20 0.53
▸ MAPT P10636 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.46
▸ HIF1A Q16665 1/20 0.46
▸ GAA P10253 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ EPHX1 P07099 4/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ ALDH1A2 O94788 1/20 0.41
▸ ALDH2 P05091 1/20 0.41
▸ ALDH1A3 P47895 1/20 0.41
▸ PRMT1 Q99873 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1591868 1.00 ZDHHC20 (0.79) ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR
SCHEMBL270209 1.00 ZDHHC20 (0.79) ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR
SCHEMBL269468 1.00 ZDHHC20 (0.79) ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR
SCHEMBL8405507 1.00 ZDHHC20 (0.79) ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR
SCHEMBL1401845 1.00 ZDHHC20 (0.79) ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR
SCHEMBL58169 1.00 ZDHHC20 (0.79) ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR
SCHEMBL632264 0.97 ZDHHC20 (0.75) ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR
SCHEMBL1561467 0.92 ZDHHC20 (0.68) ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR
SCHEMBL24652920 0.91 ZDHHC20 (0.68) ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR
SCHEMBL10777565 0.91 ALDH1A1 (0.70) ZDHHC20ZDHHC2ALDH1A1MAPK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117402362-A Synthesis method of polymer containing selenoether group, product thereof and degradation method 浙江大学 2024-01-16 — — CN claimed
EP-0606742-B1 Bile acid sequestrant ROHM & HAAS (US) 1997-11-19 — — EP claimed
US-5451397-A Crosslinked amino functional acrylic amide polymer, reducing blood cholesterol levels ROHM AND HAAS COMPANY (US) 1995-09-19 — — US claimed
EP-0606742-A1 Bile acid sequestrant ROHM AND HAAS COMPANY (US) 1994-07-20 — — EP claimed
US-20260092135-A1 POLYMER ELECTROLYTE COMPRISING A POLYACRYLAMIDE AND METHODS FOR THE PRODUCTION THEREOF UMICORE NV (BE) 2026-04-02 — — US disclosed
US-20260094823-A1 COMPOSITE CATHODE COMPRISING A POLYMER ELECTROLYTE AND NICKEL BASED CATHODE ACTIVE MATERIAL UMICORE NV (BE) 2026-04-02 — — US disclosed
US-20260088289-A1 ELECTROCHEMICAL CELL COMPRISING A POLYMER ELECTROLYTE AND A NICKEL-BASED CATHODE ACTIVE MATERIAL UMICORE NV (BE) 2026-03-26 — — US disclosed
US-20260088336-A1 ELECTROCHEMICAL CELL COMPRISING A POLYMER ELECTROLYTE AND A NICKEL BASED CATHODE ACTIVE MATERIAL UMICORE NV (BE) 2026-03-26 — — US disclosed
EP-4591370-A1 COMPOSITE CATHODE COMPRISING A POLYMER ELECTROLYTE AND NICKEL BASED CATHODE ACTIVE MATERIAL Umicore (BE) 2025-07-30 — — EP disclosed
EP-4591385-A1 ELECTROCHEMICAL CELL COMPRISING A POLYMER ELECTROLYTE AND A NICKEL-BASED CATHODE ACTIVE MATERIAL Umicore (BE) 2025-07-30 — — EP disclosed
EP-4591386-A1 ELECTROCHEMICAL CELL COMPRISING A POLYMER ELECTROLYTE AND A NICKEL BASED CATHODE ACTIVE MATERIAL Umicore (BE) 2025-07-30 — — EP disclosed
EP-4591384-A1 POLYMER ELECTROLYTE COMPRISING A POLYACRYLAMIDE AND METHODS FOR THE PRODUCTION THEREOF Umicore (BE) 2025-07-30 — — EP disclosed
EP-2491082-A1 SHAPE MEMORY POLYMERS AND PROCESS FOR PREPARING Georgia Tech Research Corporation (US) 2012-08-29 — — EP disclosed
US-20110092652-A1 SHAPE MEMORY POLYMERS AND PROCESS FOR PREPARING GEORGIA TECH RESEARCH CORPORATION 2011-04-21 — — US disclosed
US-7306884-B2 Dye-containing curable composition, color filter prepared using the same, and process of preparing color filter FUJIFILM CORPORATION (JP) 2007-12-11 — — US disclosed
US-7306884-B2 Dye-containing curable composition, color filter prepared using the same, and process of preparing color filter FUJIFILM CORPORATION (JP) 2007-12-11 — — US disclosed
US-5451397-A Crosslinked amino functional acrylic amide polymer, reducing blood cholesterol levels ROHM AND HAAS COMPANY (US) 1995-09-19 — — US disclosed
EP-0606742-A1 Bile acid sequestrant ROHM AND HAAS COMPANY (US) 1994-07-20 — — EP disclosed
US-4258121-A SULFONYLOXY N-SUBSTITUTED IMIDES AS PHOTOINITIATORS FUJI PHOTO FILM CO., LTD. (JP) 1981-03-24 — — US disclosed
US-4175964-A SUCCESSIVE SURFACE TREATMENT WITH AQUEOUS SOLUTIONS OF PHOSPHORIC ACID AND SILICIC ACID OR ITS SALTS FUJI PHOTO FILM CO., LTD. (JP) 1979-11-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260094823-A1 COMPOSITE CATHODE COMPRISING A POLYMER ELECTROLYTE AND NICKEL BASED CATHODE ACTIVE MATERIAL NES, HCN2, HCN1 ZDHHC20 4577/4885ZDHHC2 4357/4885ALDH1A1 1013/4885
US-20260092135-A1 POLYMER ELECTROLYTE COMPRISING A POLYACRYLAMIDE AND METHODS FOR THE PRODUCTION THEREOF RPL6, EFNA1, HCN1 ZDHHC20 4718/4885ZDHHC2 4581/4885ALDH1A1 2293/4885
US-20260088336-A1 ELECTROCHEMICAL CELL COMPRISING A POLYMER ELECTROLYTE AND A NICKEL BASED CATHODE ACTIVE MATERIAL NES, HCN2, CDH1 ZDHHC20 3154/4885ZDHHC2 2687/4885ALDH1A1 2448/4885
US-20260088289-A1 ELECTROCHEMICAL CELL COMPRISING A POLYMER ELECTROLYTE AND A NICKEL-BASED CATHODE ACTIVE MATERIAL NES, CDH1, EMC1 ZDHHC20 3336/4885ZDHHC2 2865/4885ALDH1A1 3359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback